About: covid:PMC7415163

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7415163 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Remuzzi, Giuseppe Fagiuoli, Stefano Frigeni, Marco Gritti, Giuseppe Landi, Francesco Rambaldi, Alessandro Binda, Francesca Borleri, Gianmaria Demopulos, Gregory Di Marco, Fabiano Gianatti, Andrea Lorini, Luca Micò, Maria Pavoni, Chiara Salvi, Anna Sonzogni, Aurelio Whitaker, Steve
is schema:about of	named entity 'Microangiopathy' named entity 'COVID-19' named entity 'Injury' named entity 'Thrombotic Microangiopathy' named entity 'Lectin pathway' named entity 'prothrombin' named entity 'vascular endothelial cells' named entity 'COVID-19' named entity 'infection' named entity 'Complement' named entity 'COVID' named entity 'Lectin pathway' named entity 'U.S. Food and Drug Administration' named entity 'non-parametric' named entity 'invasive mechanical ventilation' named entity 'MASP-2' named entity 'COVID-19' named entity 'Polymer' named entity 'autopsies' named entity 'Complement activation' named entity 'MASP-2' named entity 'COVID-19' named entity 'cobicistat' named entity 'March 2020' named entity 'H&E' named entity 'platelet' named entity 'COVID-19 outbreak' named entity 'endothelial' named entity 'severe respiratory failure' named entity 'complement factors' named entity 'CD34' named entity 'thrombosis' named entity 'graft-versus-host disease' named entity 'Biologics License Application' named entity 'Italian' named entity 'FDA' named entity 'respiratory support' named entity 'immunoglobulin' named entity 'thrombotic microangiopathy' named entity 'invasive mechanical ventilation' named entity 'ARDS' named entity 'complement pathways' named entity 'viral RNA' named entity 'COVID' named entity 'steroid' named entity 'MASP-2' named entity 'lectin pathway' named entity 'COVID' named entity 'respiratory support' named entity 'siltuximab' named entity 'clinical trial' named entity 'pulmonary embolism' named entity 'coagulation' named entity 'MASP-2' named entity 'infection' named entity 'PaO2/FiO2 ratio' named entity 'COVID' named entity 'supportive treatment' named entity 'leukocyte' named entity 'ARDS' named entity 'atypical hemolytic uremic syndrome' named entity 'COVID' named entity 'coagulation' named entity 'interleukin-10' named entity 'clinical outcomes' named entity 'Sanofi Aventis' named entity 'kallikrein' named entity 'Bergamo' named entity 'invasive mechanical ventilation' named entity 'COVID' named entity 'airway' named entity 'cytokine' named entity 'control groups' named entity 'LDH' named entity 'coagulation' named entity 'COVID' named entity 'lymphocytes' named entity 'gamma 4' named entity 'informed consent' named entity 'siltuximab' named entity 'steroid' named entity 'lectin pathway' named entity 'FDA'

Attributes

Values

Creator

Remuzzi, Giuseppe
Fagiuoli, Stefano
Frigeni, Marco
Gritti, Giuseppe
Landi, Francesco
Rambaldi, Alessandro
Binda, Francesca
Borleri, Gianmaria
Demopulos, Gregory
Di Marco, Fabiano
Gianatti, Andrea
Lorini, Luca
Micò, Maria
Pavoni, Chiara
Salvi, Anna
Sonzogni, Aurelio
Whitaker, Steve

is schema:about of

named entity 'Microangiopathy'
named entity 'COVID-19'
named entity 'Injury'
named entity 'Thrombotic Microangiopathy'
named entity 'Lectin pathway'
named entity 'prothrombin'
named entity 'vascular endothelial cells'
named entity 'COVID-19'
named entity 'infection'
named entity 'Complement'
named entity 'COVID'
named entity 'Lectin pathway'
named entity 'U.S. Food and Drug Administration'
named entity 'non-parametric'
named entity 'invasive mechanical ventilation'
named entity 'MASP-2'
named entity 'COVID-19'
named entity 'Polymer'
named entity 'autopsies'
named entity 'Complement activation'
named entity 'MASP-2'
named entity 'COVID-19'
named entity 'cobicistat'
named entity 'March 2020'
named entity 'H&E'
named entity 'platelet'
named entity 'COVID-19 outbreak'
named entity 'endothelial'
named entity 'severe respiratory failure'
named entity 'complement factors'
named entity 'CD34'
named entity 'thrombosis'
named entity 'graft-versus-host disease'
named entity 'Biologics License Application'
named entity 'Italian'
named entity 'FDA'
named entity 'respiratory support'
named entity 'immunoglobulin'
named entity 'thrombotic microangiopathy'
named entity 'invasive mechanical ventilation'
named entity 'ARDS'
named entity 'complement pathways'
named entity 'viral RNA'
named entity 'COVID'
named entity 'steroid'
named entity 'MASP-2'
named entity 'lectin pathway'
named entity 'COVID'
named entity 'respiratory support'
named entity 'siltuximab'
named entity 'clinical trial'
named entity 'pulmonary embolism'
named entity 'coagulation'
named entity 'MASP-2'
named entity 'infection'
named entity 'PaO2/FiO2 ratio'
named entity 'COVID'
named entity 'supportive treatment'
named entity 'leukocyte'
named entity 'ARDS'
named entity 'atypical hemolytic uremic syndrome'
named entity 'COVID'
named entity 'coagulation'
named entity 'interleukin-10'
named entity 'clinical outcomes'
named entity 'Sanofi Aventis'
named entity 'kallikrein'
named entity 'Bergamo'
named entity 'invasive mechanical ventilation'
named entity 'COVID'
named entity 'airway'
named entity 'cytokine'
named entity 'control groups'
named entity 'LDH'
named entity 'coagulation'
named entity 'COVID'
named entity 'lymphocytes'
named entity 'gamma 4'
named entity 'informed consent'
named entity 'siltuximab'
named entity 'steroid'
named entity 'lectin pathway'
named entity 'FDA'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software